These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11086722)

  • 1. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.
    Zlotos DP; Buller S; Tränkle C; Mohr K
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2529-32. PubMed ID: 11086722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems.
    Zlotos DP; Buller S; Stiefl N; Baumann K; Mohr K
    J Med Chem; 2004 Jul; 47(14):3561-71. PubMed ID: 15214783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.
    Zlotos DP; Gündisch D; Ferraro S; Tilotta MC; Stiefl N; Baumann K
    Bioorg Med Chem; 2004 Dec; 12(23):6277-85. PubMed ID: 15519170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
    Buller S; Zlotos DP; Mohr K; Ellis J
    Mol Pharmacol; 2002 Jan; 61(1):160-8. PubMed ID: 11752217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.
    Botero Cid MH; Holzgrabe U; Kostenis E; Mohr K; Tränkle C
    J Med Chem; 1994 May; 37(10):1439-45. PubMed ID: 8182702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors.
    Tränkle C; Elis K; Wiese M; Mohr K
    Life Sci; 1997; 60(22):1995-2003. PubMed ID: 9180353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
    Tränkle C; Mohr K
    Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors.
    Zlotos DP; Buller S; Holzgrabe U; Mohr K
    Bioorg Med Chem; 2003 Jun; 11(12):2627-34. PubMed ID: 12757728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexamethonium-type allosteric modulators of the muscarinic receptors bearing lateral dibenzazepine moieties.
    Li R; Tränkle C; Mohr K; Holzgrabe U
    Arch Pharm (Weinheim); 2001 Apr; 334(4):121-4. PubMed ID: 11382147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.
    Burgmer U; Schulz U; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):363-70. PubMed ID: 9606020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of lateral substituents in heptane-bisammonium derivatives to the allosteric stabilization of antagonist binding to M2-receptors.
    Staudt M; Tränkle C; Mohr K; Holzgrabe U
    Life Sci; 1998; 62(5):423-9. PubMed ID: 9449232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
    Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
    Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
    Tränkle C; Kostenis E; Burgmer U; Mohr K
    J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.
    Raasch A; Scharfenstein O; Tränkle C; Holzgrabe U; Mohr K
    J Med Chem; 2002 Aug; 45(17):3809-12. PubMed ID: 12166953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in a series of bisquaternary bisphthalimidine derivatives modulating the muscarinic M(2)-receptor allosterically.
    Botero Cid HM; Tränkle C; Baumann K; Pick R; Mies-Klomfass E; Kostenis E; Mohr K; Holzgrabe U
    J Med Chem; 2000 Jun; 43(11):2155-64. PubMed ID: 10841794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.